Literature DB >> 12931791

Human neural stem cells: a new tool for studying cortical development in Down's syndrome.

A Bhattacharyya1, C N Svendsen.   

Abstract

The clinical characteristics of Down's syndrome (DS), or trisomy 21, are caused by errors that occur during development. In addition to mental retardation, DS individuals have craniofacial abnormalities, clinical defects of the heart, gut and immune system, as well as predisposition to certain diseases, such as leukemias and Alzheimer's disease. To explain the developmental mechanisms that cause these traits, it is necessary to look at how developmental processes in DS compare to normal development. The neurological characteristics of DS are established during the prenatal and early postnatal period in humans, when the bulk of brain development occurs. Mouse models of DS have provided a useful way of studying DS neural development. However, there are clearly significant differences between rodent and human biology that may not be reflected in mouse models. Recent advances in stem cell biology now allow the generation of human neural tissue in the culture dish (Ostenfeld & Svendsen 2003). Stem cells offer a novel model system to study alterations in neuron development in developmental disorders such as DS.

Entities:  

Mesh:

Year:  2003        PMID: 12931791     DOI: 10.1034/j.1601-183x.2003.00025.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  9 in total

1.  Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis.

Authors:  Caroline Gregorian; Jonathan Nakashima; Janel Le Belle; John Ohab; Rachel Kim; Annie Liu; Kate Barzan Smith; Matthias Groszer; A Denise Garcia; Michael V Sofroniew; S Thomas Carmichael; Harley I Kornblum; Xin Liu; Hong Wu
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

2.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

3.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

4.  Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

Authors:  Erin L McMillan; Allison L Kamps; Samuel S Lake; Clive N Svendsen; Anita Bhattacharyya
Journal:  Am J Stem Cells       Date:  2012-06-03

Review 5.  The state of the art in stem cell biology and regenerative medicine: the end of the beginning.

Authors:  Evan Y Snyder
Journal:  Pediatr Res       Date:  2017-12-13       Impact factor: 3.756

Review 6.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

7.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

8.  A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Authors:  Anita Bhattacharyya; Erin McMillan; Serene I Chen; Kyle Wallace; Clive N Svendsen
Journal:  Dev Neurosci       Date:  2009-09-09       Impact factor: 2.984

9.  Receptor-interacting protein 140 overexpression promotes neuro-2a neuronal differentiation by ERK1/2 signaling.

Authors:  Xiao Feng; Weidong Yu; Rong Liang; Cheng Shi; Zhuran Zhao; Jingzhu Guo
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.